Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors-A nationwide survey

SSB David, N Shamir-Stein, SB Gez, U Lerner… - Clinical …, 2021 - Elsevier
Abstract Background Since July 13, 2021, a third SARS-CoV-2 vaccine BNT162b2 was
approved in Israel to immunocompromised and seniors 60 years of age or older. We aimed …
被引用次数：23 相关文章

Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors-A nationwide survey.

N Shamir-Stein, U Lerner… - Clinical Immunology …, 2021 - europepmc.org
Background Since July 13, 2021, a third SARS-CoV-2 vaccine BNT162b2 was approved in
Israel to immunocompromised and seniors 60 years of age or older. We aimed to evaluate …

Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors-a nationwide survey.

S Shapiro Ben David, N Shamir-Stein, S Baruch Gez… - 2021 - cabidigitallibrary.org
Abstract Background: Since July 13, 2021, a third SARS-CoV-2 vaccine BNT162b2 was
approved in Israel to immunocompromised and seniors 60 years of age or older. We aimed …

Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors-A nationwide survey

SSB David, N Shamir-Stein, SB Gez… - Clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Since July 13, 2021, a third SARS-CoV-2 vaccine BNT162b2 was approved in
Israel to immunocompromised and seniors 60 years of age or older. We aimed to evaluate …
[HTML] nih.gov

[HTML][HTML] Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors-A nationwide survey

SSB David, N Shamir-Stein, SB Gez… - Clinical Immunology …, 2021 - ncbi.nlm.nih.gov
Background Since July 13, 2021, a third SARS-CoV-2 vaccine BNT162b2 was approved in
Israel to immunocompromised and seniors 60 years of age or older. We aimed to evaluate …

[引用][C] Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors-A nationwide survey

SSB David, N Shamir-Stein, SB Gez, U Lerner… - Clinical …, 2021 - cir.nii.ac.jp
Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised
individuals and seniors - A nationwide survey | CiNii Research CiNii 国立情報学研究所 学術 …